|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,044.00 GBX | -0.62% |
|
+10,009.60% | +9,659.54% |
| 01-05 | Imperial Brands plc Announces Termination of Stefan Andreas Bomhard as Director, Effective December 31, 2025 | CI |
| 01-05 | FTSE 100 at record close despite Venezuela nerves | AN |
| Fiscal Period: September | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.27 | 6.64 | 6.7 | 7.78 | 7.73 | |||||
Return on Total Capital | 11.48 | 11.79 | 11.62 | 13.67 | 14 | |||||
Return On Equity % | 50.74 | 24.83 | 34.8 | 43.36 | 38.74 | |||||
Return on Common Equity | 55.44 | 25.71 | 36.15 | 45.59 | 40.35 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 36.4 | 35.71 | 36.95 | 36.67 | 36.88 | |||||
SG&A Margin | 13.31 | 16.85 | 19.02 | 17.37 | 18.46 | |||||
EBITDA Margin % | 22.1 | 21.61 | 20.73 | 22.09 | 21.22 | |||||
EBITA Margin % | 21.13 | 20.98 | 19.91 | 21.25 | 20.41 | |||||
EBIT Margin % | 18.61 | 18.86 | 17.93 | 19.3 | 18.42 | |||||
Income From Continuing Operations Margin % | 17.55 | 9.85 | 13.59 | 14.86 | 11.69 | |||||
Net Income Margin % | 17.11 | 9.29 | 12.88 | 14.14 | 10.91 | |||||
Net Avail. For Common Margin % | 17.11 | 9.29 | 12.88 | 14.14 | 10.91 | |||||
Normalized Net Income Margin | 11.87 | 11.1 | 10.06 | 9.67 | 9.63 | |||||
Levered Free Cash Flow Margin | 12.72 | 14.05 | 11.94 | 12.64 | 13.13 | |||||
Unlevered Free Cash Flow Margin | 14.37 | 15.28 | 13.4 | 14.05 | 14.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.54 | 0.56 | 0.6 | 0.65 | 0.67 | |||||
Fixed Assets Turnover | 7.98 | 8.8 | 9.44 | 9.56 | 9.94 | |||||
Receivables Turnover (Average Receivables) | 7.11 | 7.43 | 8.34 | 8.25 | 8.06 | |||||
Inventory Turnover (Average Inventory) | 2.67 | 2.73 | 2.63 | 2.72 | 2.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.76 | 0.8 | 0.72 | 0.72 | 0.74 | |||||
Quick Ratio | 0.39 | 0.41 | 0.32 | 0.34 | 0.35 | |||||
Operating Cash Flow to Current Liabilities | 0.2 | 0.29 | 0.26 | 0.29 | 0.31 | |||||
Days Sales Outstanding (Average Receivables) | 51.36 | 49.1 | 43.75 | 44.34 | 45.29 | |||||
Days Outstanding Inventory (Average Inventory) | 136.85 | 133.89 | 138.7 | 134.46 | 130.17 | |||||
Average Days Payable Outstanding | 39.13 | 38.59 | 44.19 | 48.83 | 47.34 | |||||
Cash Conversion Cycle (Average Days) | 149.08 | 144.4 | 138.27 | 129.97 | 128.12 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 170.13 | 137.71 | 157.3 | 157.6 | 189.01 | |||||
Total Debt / Total Capital | 62.98 | 57.93 | 61.14 | 61.18 | 65.4 | |||||
LT Debt/Equity | 149.98 | 122.92 | 132.52 | 135.53 | 167.53 | |||||
Long-Term Debt / Total Capital | 55.52 | 51.71 | 51.5 | 52.61 | 57.97 | |||||
Total Liabilities / Total Assets | 79.58 | 75.86 | 77.48 | 78.33 | 81.08 | |||||
EBIT / Interest Expense | 7.09 | 9.52 | 7.68 | 8.54 | 8.19 | |||||
EBITDA / Interest Expense | 8.57 | 11.13 | 9.08 | 10 | 9.67 | |||||
(EBITDA - Capex) / Interest Expense | 8.11 | 10.44 | 8.31 | 9.11 | 9.21 | |||||
Total Debt / EBITDA | 2.71 | 2.76 | 2.73 | 2.27 | 2.49 | |||||
Net Debt / EBITDA | 2.35 | 2.26 | 2.37 | 2 | 2.13 | |||||
Total Debt / (EBITDA - Capex) | 2.87 | 2.94 | 2.98 | 2.5 | 2.61 | |||||
Net Debt / (EBITDA - Capex) | 2.48 | 2.41 | 2.59 | 2.2 | 2.24 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -0.23 | 2.08 | 6.92 | 2.26 | 2.69 | |||||
Gross Profit, 1 Yr. Growth % | -2.77 | 0.18 | 10.63 | 1.48 | 3.29 | |||||
EBITDA, 1 Yr. Growth % | 0.03 | -6.6 | 2.68 | 0.12 | -1.32 | |||||
EBITA, 1 Yr. Growth % | 0.4 | -5.44 | 1.58 | 0 | -1.4 | |||||
EBIT, 1 Yr. Growth % | 5.04 | -4.32 | 1.76 | -0.08 | -1.99 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 86.59 | -42.72 | 47.51 | 11.85 | -19.18 | |||||
Net Income, 1 Yr. Growth % | 89.57 | -44.6 | 48.28 | 12.24 | -20.74 | |||||
Normalized Net Income, 1 Yr. Growth % | 32.54 | -11.52 | -2.99 | -7.84 | 2.24 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 89.18 | -44.93 | 52.28 | 19.22 | -16.62 | |||||
Accounts Receivable, 1 Yr. Growth % | 2.83 | -7.49 | -1.74 | 8.52 | 2.1 | |||||
Inventory, 1 Yr. Growth % | -5.68 | 7.98 | 9.23 | -9.77 | 9.46 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -10.72 | -3.58 | 2.97 | -1.03 | -1.35 | |||||
Total Assets, 1 Yr. Growth % | -9.97 | 6.42 | -4.74 | -5.65 | 3.19 | |||||
Tangible Book Value, 1 Yr. Growth % | -14.8 | -3.58 | 0.05 | -3.91 | 8.46 | |||||
Common Equity, 1 Yr. Growth % | 9.87 | 28.18 | -12.23 | -9.62 | -11.36 | |||||
Cash From Operations, 1 Yr. Growth % | -46.23 | 47.02 | -1.79 | 5.69 | 9.68 | |||||
Capital Expenditures, 1 Yr. Growth % | -33.77 | 15 | 41.3 | 14.15 | 19.28 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -35.6 | 4.88 | -9.04 | -1.16 | 6.68 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -32.92 | 1.89 | -6.2 | -1.14 | 6.22 | |||||
Dividend Per Share, 1 Yr. Growth % | 0.99 | 1.5 | 4 | 4.5 | 4.5 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.11 | 0.92 | 4.47 | 4.57 | 2.48 | |||||
Gross Profit, 2 Yr. CAGR % | -0.6 | -1.32 | 5.28 | 5.96 | 2.38 | |||||
EBITDA, 2 Yr. CAGR % | 0.75 | -0.08 | -2.12 | 5.77 | -0.6 | |||||
EBITA, 2 Yr. CAGR % | 0.85 | 0.87 | -2.05 | 5.31 | -0.7 | |||||
EBIT, 2 Yr. CAGR % | 8.19 | 4.26 | -1.39 | 5.84 | -1.04 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 63.99 | 3.38 | -8.08 | 28.45 | -4.93 | |||||
Net Income, 2 Yr. CAGR % | 67.51 | 2.48 | -9.37 | 29.01 | -5.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | 20.67 | 12.53 | -7.42 | -2.33 | -2.94 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 68.14 | 2.07 | -8.43 | 34.74 | -0.3 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.3 | -2.47 | -4.66 | 3.26 | 5.26 | |||||
Inventory, 2 Yr. CAGR % | -3.09 | 0.92 | 8.6 | -0.73 | -0.62 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.56 | -7.22 | -0.36 | 0.95 | -1.19 | |||||
Total Assets, 2 Yr. CAGR % | -6.22 | -2.11 | 0.69 | -5.19 | -1.32 | |||||
Tangible Book Value, 2 Yr. CAGR % | -8.96 | -9.36 | -1.78 | -1.95 | 2.09 | |||||
Common Equity, 2 Yr. CAGR % | 4.12 | 18.67 | 6.07 | -10.93 | -10.49 | |||||
Cash From Operations, 2 Yr. CAGR % | -18.17 | -11.09 | 20.16 | 1.88 | 7.66 | |||||
Capital Expenditures, 2 Yr. CAGR % | -30.07 | -12.73 | 27.48 | 27.01 | -21.95 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 31.03 | -14.81 | -2.38 | -0.75 | 2.68 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 25.17 | -14.64 | -2.28 | 0.32 | 2.48 | |||||
Dividend Per Share, 2 Yr. CAGR % | -17.95 | 1.25 | 2.74 | 4.25 | 4.5 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 2.53 | 1.43 | 2.88 | 3.73 | 3.94 | |||||
Gross Profit, 3 Yr. CAGR % | 0.1 | -0.35 | 2.52 | 4 | 5.06 | |||||
EBITDA, 3 Yr. CAGR % | -1.24 | 0.43 | 0.8 | 1.44 | 3.35 | |||||
EBITA, 3 Yr. CAGR % | -1.16 | 1.02 | 1.07 | 1.56 | 3.02 | |||||
EBIT, 3 Yr. CAGR % | 6.22 | 6.59 | 3.37 | 2.3 | 3.16 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 26.77 | 15.49 | 16.38 | -1.87 | 10.06 | |||||
Net Income, 3 Yr. CAGR % | 27.48 | 15.84 | 15.91 | -2.67 | 9.67 | |||||
Normalized Net Income, 3 Yr. CAGR % | 15.6 | 11.63 | 7.05 | -5.54 | -0.83 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 27.83 | 15.9 | 16.63 | -0.01 | 14.82 | |||||
Accounts Receivable, 3 Yr. CAGR % | 0.77 | -4.72 | -2.22 | -0.45 | 2.87 | |||||
Inventory, 3 Yr. CAGR % | 1.27 | 0.47 | 3.62 | 2.09 | 2.56 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 1.15 | -1.57 | -3.94 | -0.58 | 0.18 | |||||
Total Assets, 3 Yr. CAGR % | -1.94 | -2.18 | -3 | -1.47 | -2.48 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.34 | -7.2 | -6.33 | -2.49 | 1.41 | |||||
Common Equity, 3 Yr. CAGR % | -2.48 | 11.59 | 7.32 | 0.56 | -11.07 | |||||
Cash From Operations, 3 Yr. CAGR % | -11.13 | -0.52 | -8.09 | 15.13 | 4.42 | |||||
Capital Expenditures, 3 Yr. CAGR % | -15.12 | -17.46 | 2.48 | 22.87 | -4.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.03 | 24.61 | -12.96 | 1.06 | 1.67 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -4.06 | 19.39 | -11.94 | 0.81 | 2.25 | |||||
Dividend Per Share, 3 Yr. CAGR % | -9.52 | -11.92 | 2.16 | 3.33 | 4.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 3.27 | 2.04 | 3.3 | 2.68 | 2.72 | |||||
Gross Profit, 5 Yr. CAGR % | 0.24 | -1.24 | 2.14 | 2.13 | 2.46 | |||||
EBITDA, 5 Yr. CAGR % | -0.16 | -1.41 | -0.28 | 2.51 | 1.94 | |||||
EBITA, 5 Yr. CAGR % | -0.15 | -1.04 | -0.14 | 2.69 | 2.13 | |||||
EBIT, 5 Yr. CAGR % | 4.13 | 3.82 | 4.73 | 6.27 | 3.57 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 34.15 | 2.85 | 11.47 | 20.51 | 7.34 | |||||
Net Income, 5 Yr. CAGR % | 35.04 | 2.19 | 11.22 | 20.94 | 6.74 | |||||
Normalized Net Income, 5 Yr. CAGR % | 22.21 | 6.51 | 7.41 | 5.79 | 4.28 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 35.29 | 2.27 | 11.86 | 23.09 | 9.54 | |||||
Accounts Receivable, 5 Yr. CAGR % | -0.46 | -1.08 | -1.44 | -1.6 | 0.7 | |||||
Inventory, 5 Yr. CAGR % | 1.85 | 2.81 | 4.14 | -0.01 | 1.9 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.02 | 0.23 | 0.54 | -0.57 | -2.85 | |||||
Total Assets, 5 Yr. CAGR % | -2.33 | -0.02 | -0.9 | -3.4 | -2.33 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.96 | -4.96 | -3.93 | -5.13 | -3.05 | |||||
Common Equity, 5 Yr. CAGR % | 0.15 | 3.83 | 0.86 | 1.97 | -0.19 | |||||
Cash From Operations, 5 Yr. CAGR % | -7.25 | 0.78 | 0.27 | 0.44 | -2.09 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.05 | 3.79 | -0.12 | -1.93 | -8.1 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -5.57 | 0.5 | -1.97 | 13.74 | -5.3 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -5.39 | -0.57 | -2.11 | 11.34 | -4.89 | |||||
Dividend Per Share, 5 Yr. CAGR % | -2.17 | -3.73 | -4.8 | -5.78 | 3.09 |
- Stock Market
- Equities
- IMB Stock
- Financials Imperial Brands PLC
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















